Lutetium Vipivotide Tetraxetan
ATC — · 4 markets · 5 records
AU 2 records · 2 strengths
- 1,000 MBq/mLinjectionPLUVICTO lutetium (177Lu) vipivotide tetraxetan 1000 MBq/mL solution for injection vial
Records without a stated strength · 1 PLUVICTO
SG 1 records · 1 strengths
- 1,000 MBq/mLinjectionPLUVICTO SOLUTION FOR INJECTION/INFUSION 1000 MBq/mL
HK 1 records · 1 strengths
Records without a stated strength · 1 PLUVICTO SOLUTION FOR INJECTION/INFUSION 1000 MBq/mL
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 PLUVICTO
| Strength / form / release | AU | SG | HK | EU |
|---|---|---|---|---|
| 1,000 MBq/mL injection | PLUVICTO lutetium (177Lu) vipivotide tetraxetan 1000 MBq/mL solution for injection vial | PLUVICTO SOLUTION FOR INJECTION/INFUSION 1000 MBq/mL | ||
unknown | PLUVICTO | PLUVICTO SOLUTION FOR INJECTION/INFUSION 1000 MBq/mL | PLUVICTO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.